Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
BLANKET PURCHASE AGREEMENT FOR CHEMISTRY COST PER REPORTABLE ADD SCHEDULE TO BASE BPA MOD P00007 is a federal award for Network Contract Office 23 (36C263) held by Roche Diagnostics Corp. Estimated value $593K ($498K obligated). Current period of performance ends Sep 30, 2022. Place of performance: INDIANAPOLIS IN. Related solicitation 36C263-21-AP-4548.
BLANKET PURCHASE AGREEMENT FOR CHEMISTRY COST PER REPORTABLE ADD SCHEDULE TO BASE BPA MOD P00007
Recompete timing
PublicCurrent PoP ended Sep 30, 2022 (1422 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordRoche Diagnostics Corp — $245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C26321N0964?
36C26321N0964 (Blanket purchase agreement for chemistry COST) is a Network Contract Office 23 (36C263) award with a potential value of $593K, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C263-21-N-0964?
36C263-21-N-0964 is the dashed form of PIID 36C26321N0964 (Blanket purchase agreement for chemistry COST), held by Roche Diagnostics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C26321N0964?
Network Contract Office 23 (36C263) awarded 36C26321N0964 to Roche Diagnostics Corp (potential $593K).
Who is the incumbent on 36C26321N0964?
Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2022.
When does Roche Diagnostics Corp’s 36C26321N0964 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.